pitavastatin ODT (AJU-C716)
/ AJU Pharm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 11, 2026
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
(clinicaltrials.gov)
- P1 | N=41 | Completed | Sponsor: AJU Pharm Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Dyslipidemia • Metabolic Disorders
June 19, 2026
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
(clinicaltrials.gov)
- P1 | N=41 | Active, not recruiting | Sponsor: AJU Pharm Co., Ltd.
New P1 trial • Dyslipidemia • Metabolic Disorders
1 to 2
Of
2
Go to page
1